{
    "clinical_study": {
        "@rank": "127805", 
        "arm_group": [
            {
                "arm_group_label": "Mood disorder patients", 
                "description": "Patients with depressive and/or manic or hypomanic symptoms"
            }, 
            {
                "arm_group_label": "Healthy controls", 
                "description": "Participants with no lifetime history of psychiatric illness"
            }
        ], 
        "brief_summary": {
            "textblock": "This study aims to investigate reward learning across the mood disorder spectrum and to\n      investigate the predictive validity of reward learning for subsequent symptom severity."
        }, 
        "brief_title": "Brain Mechanisms of Human Motivation", 
        "completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Major Depressive Disorder", 
            "Bipolar Disorder"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bipolar Disorder", 
                "Depressive Disorder", 
                "Depression", 
                "Depressive Disorder, Major"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study involves three sessions. In the first session, participants will play a computer\n      task. In the second session, participants will go through a clinical interview and will have\n      an EEG recording while playing another computer task. In the third session, participants\n      will undergo an fMRI scan while playing another computer task. All tasks assess reward\n      learning. At three and six months after the final session, researchers will follow up with\n      participants by phone to assess symptom severity. There will be no intervention in this\n      study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Written informed consent\n\n          -  Right-handed\n\n          -  (For mood disorder group only) Stable medication over the past 8 weeks OR absence of\n             any psychotropic medications for at least 2 weeks (for follow-up analyses testing\n             effects in medication-free patients):\n\n               -  6 weeks for fluoxetine,\n\n               -  6 months for neuroleptics,\n\n               -  2 weeks for benzodiazepines,\n\n               -  2 weeks for any other antidepressants\n\n               -  4 weeks for any mood-stabilizers\n\n        Exclusion Criteria:\n\n          -  Suicidal ideation where outpatient treatment is determined unsafe by the study\n             clinician\n\n          -  Pregnant women or women of childbearing potential who 1) have not completed a\n             negative urine pregnancy test prior to the MRI scan and/or 2) are seeking to become\n             pregnant or believe that they may be pregnant\n\n          -  Serious/unstable medical illness (e.g., cardiovascular, renal, endocrine, neurologic\n             disease)\n\n          -  Clinical or laboratory evidence of hypothyroidism\n\n          -  History of seizure disorder, history or current diagnosis of dementia, score < 26 on\n             the MMSE at screening\n\n          -  History or current diagnosis of the following DSM-IV psychiatric illness: organic\n             mental disorder, schizophrenia, schizoaffective disorder, delusional disorder,\n             psychotic disorder NOS, patients with mood congruent or mood incongruent psychotic\n             features\n\n          -  Lifetime history of stimulant dependence (e.g., cocaine, amphetamines)\n\n          -  Current use of Methylphenidate (Ritalin) and other ADHD medications with dopaminergic\n             effects\n\n          -  Patients with a lifetime history of electroconvulsive therapy (ECT)\n\n          -  Failure to meet standard MRI safety requirements"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "We are studying a population with depressive and/or manic or hypomanic symptoms, as well\n        as healthy controls."
            }
        }, 
        "enrollment": {
            "#text": "192", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976975", 
            "org_study_id": "2013-P-001352"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Depression", 
            "Major Depressive Disorder", 
            "Bipolar Disorder", 
            "Mania", 
            "Hypermania", 
            "EEG", 
            "MRI", 
            "Reward"
        ], 
        "lastchanged_date": "April 16, 2014", 
        "location": {
            "contact": {
                "email": "awhitton@mclean.harvard.edu", 
                "last_name": "Alexis Whitton, Ph.D.", 
                "phone": "617-855-2132"
            }, 
            "contact_backup": {
                "email": "mbeltzer@mclean.harvard.edu", 
                "last_name": "Miranda Beltzer, BA", 
                "phone": "6178554237"
            }, 
            "facility": {
                "address": {
                    "city": "Belmont", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02478"
                }, 
                "name": "McLean Hospital"
            }, 
            "investigator": {
                "last_name": "Diego A Pizzagalli, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Multi Level Analysis of Positive Valence Systems Across Mood Disorders", 
        "overall_official": {
            "affiliation": "Mclean Hospital", 
            "last_name": "Diego A Pizzagalli, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The probabilistic reward task is designed to measure sensitivity to reward and reward learning. It will be administered three times during session 1 to calculate changes in reward sensitivity.", 
                "measure": "Behavioral Performance in Probabilistic Reward Task", 
                "safety_issue": "No", 
                "time_frame": "Given once during the second session for a total of 10 minutes"
            }, 
            {
                "description": "The instrumental learning task is designed to measure participant learning from reward and punishment.", 
                "measure": "Behavioral Performance in Instrumental Learning Task", 
                "safety_issue": "No", 
                "time_frame": "Administered in session 3 during two hour long scan"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976975"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mclean Hospital", 
            "investigator_full_name": "Diego A. Pizzagalli", 
            "investigator_title": "Associate Professor, Department of Psychiatry, Harvard Medical School", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Participants will report on the phone about their symptom severity after completing all sessions.", 
            "measure": "Symptom severity", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Mclean Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mclean Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}